CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.
Patients with neuroendocrine tumors have more treatment options than ever before.
December 16th 2024, 10:00pm
The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak or observation.
December 13th 2024, 4:00pm
From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the cancer space this week.
November 23rd 2024, 3:00pm
Researchers observed responses in patients with synovial sarcoma or myxoid/round cell liposarcoma treated with lete-cel.
November 12th 2024, 4:12pm
Three cycles of chemotherapy were found to face similar results as six cycles among children with retinoblastoma, a type of cancer of the eye.
November 8th 2024, 4:00pm
From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal cancer diagnosis, here’s what’s happening in the cancer space this week.
October 8th 2024, 9:00pm
Among patients with Merkel cell carcinoma, using ctDNA testing may help with watching the disease for potential recurrences and those who are high-risk.
August 7th 2024, 7:00pm
The FDA will review an application for Cabometyx as a potential treatment for pancreatic neuroendocrine tumors after findings from a phase 3 trial.
August 6th 2024, 5:00pm
Understanding how I fit in matters to me but figuring out my identity in the cancer space is not always easy.
August 2nd 2024, 3:00pm
From “Top Chef’” Shirley Chung and comedian Christina Pazsitzky announcing their diagnoses to Erica Ash’s death from the disease, here is what’s happening in the oncology space this week.
July 23rd 2024, 1:00pm
I was thankful to find the Imerman Angels after being diagnosed with a rare form of cancer.
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Darzalex Regimen May Improve MRD Responses in Multiple Myeloma
How to Self Advocate When Insurance Says No to Cancer Treatment Coverage
FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset